InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Eizen Joshua M. Director active across 1 company, notably AN2 Therapeutics, Inc.. Aggregated, 6 filings have been recorded. Split: 0 buy · 1 sell. Total volume traded: €13k. Activity tracked since 15 March 2024. The latest transaction was filed on 26 February 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
6 of 6 declarations